Maternal OAA score (observer assessment of alertness/sedation) < 4 (Maternal sedation measured using sedation scores as defined by authors) · health problem or population
Summary of findings table ‐ Remifentanil may leads to lower maternal OAA score (observer assessment of alertness/sedation) < 4… compared with diazepam (low certainty).
1 finding from 1 review
Perinatal mortality · health problem or population
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Time taken to perform procedure · health problem or population
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life: clinically important change ‐ not measured · patients with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Hospital readmission · patients with schizophrenia
It is very uncertain whether summary of findings table ‐ Continuation changes service use – readmission to hospital – total compared with reduction of polypharmacy (very low certainty).
1 finding from 1 review
Adverse effects – leaving the study early due to adverse effects – overall tolerability – total · patients with schizophrenia
It is very uncertain whether summary of findings table ‐ Continuation changes adverse effects – leaving the study early due to adverse effects –… compared with reduction of polypharmacy (very low certainty).
1 finding from 1 review
Functioning at · patients with schizophrenia
1 finding from 1 review
Global state: relapse/exacerbations of psychosis ‐ not reported · patients with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Leaving the study early ‐ for any reason ‐ overall acceptability (combined time points) · patients with schizophrenia
Summary of findings table ‐ Continuation may leads to lower leaving the study early due to any reason – overall acceptability… compared with reduction of polypharmacy (low certainty).
1 finding from 1 review
Adverse effects: ≥ 1 adverse effect – total · patients with schizophrenia
It is very uncertain whether summary of findings table ‐ Continuation changes adverse effects: ≥ 1 adverse effect – total compared with reduction of polypharmacy (very low certainty).
1 finding from 1 review
Effectiveness of treatment · health problem or population
3 findings from 1 review
no estimate extracted
1 study · 43 participants
Low
no estimate extracted
1 study · 43 participants
Low
no estimate extracted
1 study · 43 participants
Very low
Adverse events · health problem or population
1 finding from 1 review
Psychological outcomes ‐ not reported · health problem or population
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life · health problem or population
2 findings from 1 review
Requirement for analgesia ‐ not reported · health problem or population
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Frequency, severity or duration of painful crises · children with SCD
1 finding from 1 review
Frequency of severe complications of SCD · children with SCD
1 finding from 1 review
Frequency of hospital admissions from severe complications of SCD · children with SCD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Any adverse events including hepatic and renal toxicity · children with SCD
1 finding from 1 review
Frequency of blood transfusion · children with SCD
1 finding from 1 review